Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cross-sectional study was undertaken to determine the prevalence of Mycoplasma fermentans infection in patients with human immunodeficiency virus (HIV) infection using polymerase chain reaction methodology. Targeted M. fermentans DNA sequences could be amplified from the DNA extracted from the blood of 6 (11%) of 55 HIV-seropositive patients but from none of 26 HIV-seronegative subjects at low risk for
HIV infection
(P = .17). There was no correlation between M. fermentans infection and HIV clinical stage. There was a nonsignificant trend toward an association between M. fermentans infection and a history of syphilis.
Infection
with M. fermentans may occur more commonly in HIV-infected patients; however, a role as a copathogen or opportunistic infection was not established in this study.
...
PMID:Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. 153 64
Human immunodeficiency virus type 1 (HIV-1), the agent of AIDS, frequently infects the central nervous system. We inoculated adult human brain cultures with chimeric viruses containing parts of the env gene of a cloned primary isolate from brain tissue,
HIV
-1 JRFl, inserted into the cloned DNA of a T-cell-tropic strain. A chimeric virus containing the carboxy-terminal portion of
HIV
-1 JRFl env did not replicate in these brain tissue cultures, while a chimera expressing an env-encoded protein containing 158 amino acids of
HIV
-1 JRFl gp120, including the V3 loop, replicated well in brain microglial cells, as it does in blood macrophages.
Infection
of brain microglial cells with such a chimera was blocked by an antibody to the V3 loop of gp 120. Thus, env determinants in the region of gp120, outside the CD4-binding site and comprising the V3 loop, are critical for efficient viral binding to and/or entry into human brain microglia.
...
PMID:Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. 154 85
Infection
by human immunodeficiency viruses (HIV) is associated with an increased incidence of non-Hodgkin's lymphomas (NHL) of B cell origin and of intermediate grade (diffuse large cell lymphomas according to the Working Formulation) or high grade (Kiel classification and Working Formulation). They may be either primary central nervous system lymphomas or systemic lymphomas and are considered as AIDS-defining events. Systemic lymphomas are usually disseminated with a high frequency of extranodal sites. Their overall prognosis is much worse than for NHL in the general population. Pathogenesis is still a matter of debate. An increased incidence of Hodgkin's diseases (HD) in
HIV infection
is being suspected but has not been proved yet. However, HIV-associated HD differ from usual HD by clinical presentation, histological type repartition, and evolution. Finally, low grade lymphomas have been described in
HIV infection
, the only peculiarity being the unusual age of occurrence.
...
PMID:[Human immunodeficiency virus infection and malignant lymphoma]. 156 99
In the present paper the authors review the biological properties of the
HIV infection
. The preferential target of
HIV infection
is the lymphocyte that expresses the CD4 phenotype.
Infection
of CD4 subsets leads to a remarkable cytopathic effect that can be blocked by antibodies anti CD4 epitope. Actually the
HIV
envelope proteins recognize an epitope of the CD4 surface molecules; as consequence the antibodies anti idiotypic directed to CD4 indirectly present the binding of envelope proteins to CD4. The relationship between this retrovirus and the immunological pathogenesis of the disease are also discussed.
HIV infection
is facilitated in groups affected by alterations of the immune system as drug abusers, haemophiliacs and homosexuals. Secondary immunological abnormalities are consistently pronounced in people seropositive for the virus and affected by a progressive generalized lymphoadenopathy (PGL). The degeneration of primary lymphatic organs causes a reduction of the T-cell response against any antigenic challenge. After the PGL phase the disease shifts on AIDS, that is an irreversible stadium accompanied by the deterioration of the clinical status and by an increase of immunosuppression that favours the arise of tumours. In addiction
HIV infection
may cause severe central nervous system (CNS) dysfunctions, the
HIV
associated neurological syndromes include myelopathy, meningitis, encephalitis and peripheral neuropathy.
HIV
has also been isolated from brain tissue and from cerebral spinal fluid.
...
PMID:Biological aspects of HIV infection. 156 58
Mycobacteria are acid-fast, slow-growing microorganisms which have gained attention due to increasing prevalence in AIDS patients. Until the advent of AIDS, the only true pathogens of this group were Mycobacterium tuberculosis and M. leprae and the remaining mycobacteria were considered to be saprophytes or opportunistic pathogens.
Infection
with the MOTT (mycobacteria other than tuberculosis) bacilli was only seen in elderly or immunocompromised patients and was generally limited to caseating pulmonary granulomas, with rare extrapulmonary involvement. In AIDS patients, however, the incidence of mycobacterial infections ranges from 10 to 60% of
HIV
-positive persons, depending on location, method of identification, and patient population. Furthermore the pathogenesis of these mycobacterioses is distinct from that seen in non-AIDS patients because disseminated disease is the rule rather than the exception. Finally treatment of mycobacterial infections is increasingly difficult due to multiple drug resistances as well as the length of antimicrobial therapy required to cure the disease. Because of the prevalence and importance of these microorganisms, much research has been performed with the mycobacteria to develop new therapies and to understand their modes of pathogenesis.
...
PMID:Mycobacteria and AIDS. 157 82
Infection
with the human immunodeficiency virus (HIV) has become an increasingly important public health problem. Due to the profound increase in the incidence of the disease, testing has become an important tool in prevention efforts as well as treatment. In view of the dire prognosis associated with the diagnosis of
HIV infection
, there is a great deal of interest in mandatory HIV testing of special groups. Mandatory testing has been implemented for several groups such as the United States military. However, there are a number of issues to be considered before implementing a mandatory testing program. These include the predictive value and accuracy of the tests themselves, confidentiality and the social ramifications of breaches in confidentiality, the likelihood of forcing high risk persons underground to avoid testing, and the constitutionality of a mandatory testing policy. Since the discovery of the apparent transmission of
HIV infection
from a dentist to his patients, there has been increasing interest in a policy mandating the testing of health professionals. However, in view of the low risk of transmission to patients, it would be ill-advised to require HIV testing of health care workers. In general, the benefits of a mandatory testing policy do not outweigh the human and financial costs it would engender.
...
PMID:The feasibility of mandatory HIV testing for health professionals and other special populations. 157 74
Infection
with
HIV
is a problem of growing magnitude among women and children in the United States. During 1991, AIDS will be among the five leading causes of death for women of childbearing age. Over 80% of children with
HIV
have acquired the infection vertically, and AIDS is now a leading cause of death of children in many urban areas of the United States. Gender and age have important influences on the progression of
HIV disease
and on the occurrence of complicating illnesses. Zidovudine can slow HIV disease progression, and several regimens of prophylaxis are effective against P. carinii pneumonia, which is the leading cause of death among adults and children with AIDS. Intravenous immunoglobulin may be effective for prevention of serious infections in some children with symptomatic
HIV infection
. Ultimately, prevention of
HIV infection
among women and children depends on targeted education and, possibly, the development of medical strategies for interruption of vertical transmission.
...
PMID:Impact of human immunodeficiency virus infection on women and infants. 157 10
Infection
with the human immunodeficiency virus type 1 (HIV-1) results in a variety of pathological changes culminating in the acquired immune deficiency syndrome (AIDS). While most of these changes can readily be accounted for either by direct effects of
HIV
-1 on the immune system or by indirect effects of secondary infectious agents as a result of faulty immune surveillance, the direct cause for a number of disease states, including some neuropathies, myopathies, nephropathy, thrombocytopenia, wasting syndromes and increased incidence of cancers (primarily lymphoma) has remained an enigma. We have recently shown that the HIV-1 protease, a viral encoded enzyme necessary for virus maturation and infectivity, can cleave a variety of host cell cytoskeletal proteins in vitro. Potential substrates for the HIV-1 protease are found in all of the cell types affected in these unexplained diseases. Recent proposals suggest that elements of the cytoskeleton may play an important role in the regulation of large scale genetic regulation. We propose that some of the degenerative changes associated with infection by
HIV
-1 are a direct consequence of cleavage of host cell cytoskeletal proteins, which in turn may be responsible for the increased incidence of cancer in
HIV
-1 infected individuals as a result of the perturbation of the regulation of gene expression by cytoskeletal components.
...
PMID:Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis. 158 3
Infection
with the human immunodeficiency virus type 1 (HIV-1) results in decreased cell-mediated immunity, which includes decreased delayed hypersensitivity to skin test antigens.
HIV
-1 seropositivity and skin test reactivity to purified protein derivative (PPD) were determined among 2042 healthy Haitian adults with normal chest radiographs. Among
HIV
-1-seropositive individuals, 52.3% (146/279) had PPD reactions greater than or equal to 10 mm compared with 67.2% (1184/1763) of the seronegative adults (P less than .001). However, the percentage of
HIV
-1-seropositive individuals with PPD reactions greater than or equal to 5 mm was similar to the percentage of seronegative adults with PPD reactions greater than or equal to 10 mm (180/279 [64.5%] vs. 1184/1763 [67.2%]). Assuming that the rate of prior infection with Mycobacterium tuberculosis was similar for
HIV
-1-seronegative and -seropositive populations, these data provide support for the recent recommendations to use induration of greater than or equal to 5 mm as evidence of past infection with M. tuberculosis in
HIV
-1 seropositive adults.
...
PMID:Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. 160 96
Peripheral blood mononuclear cells (PBMCs) from
HIV
-seronegative donors were infected in vitro with
HIV
-1.
Infection
was monitored by cytopathology, supernatant p24 antigen, and by immunocytochemical staining. After 14 days in culture, approximately 70-90% of the cells became infected with
HIV
, as indicated by cell fusion and immunostaining for virus. At this time, recombinant HuIFN-gamma was added to the cultures, followed by infection 24 h later with the intracellular protozoan parasites Toxoplasma gondii, Trypanosoma cruzi, or Leishmania chagasi. Percentages of intracellular parasites were determined at various points thereafter. Using a system capable of detecting both virus and parasite infection, we determined that (a) cells infected with
HIV
were capable of ingesting and/or being infected by each of these parasitic protozoa, (b)
HIV
-infected macrophages could be activated to inhibit the replication of all three parasites following treatment with IFN-gamma, and (c) cultures of
HIV
-infected macrophages could respond to IFN-gamma with increased oxidative burst activity. The degree of parasite infection or inhibition observed in infected cells was not significantly different from that observed in non-
HIV
-infected cells. From these observations, we concluded that
HIV
-1 infection does not render macrophages unresponsive to IFN-gamma activation for microbicidal activity.
...
PMID:Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. 161 64
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>